Lenalidomide is the active component of the drug LENSHIL Capsules 10 mg. Lenalidomide is an immunomodulatory medication used to treat some blood conditions and malignancies. It is typically used for myelodysplastic syndromes (MDS) and multiple myeloma, a type of blood malignancy. Lenalidomide controls the immune system and stops the development of aberrant cells. LENSHEL Capsules are often used in conjunction with other drugs and are swallowed orally. Fatigue, low blood cell counts, and an increased risk of infections are examples of frequent adverse effects. In order to manage potential adverse effects and guarantee treatment effectiveness in patients with blood disorders or multiple myeloma, regular medical monitoring is essential throughout the course of the treatment.
Lenalidomide, the active ingredient in LENSHIL Capsules 10 mg, is primarily used to treat the following conditions:
1. Plasma cells in the bone marrow are affected by the blood malignancy multiple myeloma, which is treated with LENSHIL in combination with other drugs.
2. LENSHIL is a medication used to treat some kinds of myelodysplastic syndromes (MDS), a class of diseases in which the bone marrow fails to create enough healthy blood cells.
The adverse effects of LENSHIL Capsules 10 mg can take many different forms, and each person will experience them differently. Typical negative consequences could be:
1. Lenalidomide can cause a reduction in platelets, white blood cells, and red blood cells, which raises the risk of anaemia, infections, and bleeding issues.
2. Patients may feel weary or weak due to fatigue.
3. Vomiting and Nausea: Some people may feel sick to their stomachs and feel like they are about to throw up.
4. Constipation or Diarrhoea: Modifications in bowel habits, such as constipation or diarrhoea, might happen.
5. Skin Rash: Lenalidomide may result in allergic reactions or skin rashes.
6. Muscle Pain: Some people may experience pain or discomfort in their muscles.
7. Headache or dizziness: Patients may feel dizzy or have headaches.
8. Lenalidomide may make you more susceptible to infections because of how it affects your immune system.
9. Some people with peripheral neuropathy may feel tingling or numbness in their hands and feet.
10. Rarely, the drug lenalidomide may make blood clots including deep vein thrombosis (DVT) and pulmonary embolism more likely.
11. Lenalidomide has a significant teratogenic potential, which increases the risk of serious birth abnormalities. As a result, pregnant women must adhere to strict pregnancy prevention guidelines.
Medical personnel should closely supervise patients while they are receiving LENSHIL Capsules 10 mg. Any symptoms that warrant further investigation should be reported right away to the healthcare professional as the medication carries a potential for serious adverse effects. Oncologists or other healthcare professionals skilled in treating multiple myeloma, myelodysplastic syndromes, or other similar blood disorders should be consulted before treatment decisions are made. Furthermore, for women who are capable of becoming pregnant, stringent pregnancy prevention measures must be taken due to its teratogenic effects.